If you ever wanted to see a real documentary about AIDS. I advise for you to see this video, which contains a story of young man who wanted to make a difference knowing that He was going to die from the one or more opportunistic diseases from the HIV virus . Please copy and paste the links, to see the videos. If you never seen what & how this HIV Virus affects those who are positive in so many ways and their love ones. Then I say to you take the time to view this video.

 World AIDS Day 2015 is around the corner December 1st for those who never heard this day. In fact this day has been around since 1988, to honor those who had died from HIV Virus. There are other movies that you can watch especially  “And The Band Played On 1993”

FB_20140201_08_42_56_Saved_Picture       FB_20140201_08_43_21_Saved_Picture




Part 2 of 3


Part 3 of 3


Leading with Race Honoring National Latino AIDS Awareness Day 2015


In this Special Edition Newsletter, NMAC recognizes Latino HIV/AIDS Awareness Day. We spotlight Rodrigo Pascal, a Latino activist and advocate from Chile, South America for his global role in fighting prejudices against people with HIV/AIDS.  We continue the newsletter with a profile of three Latino youth leaders in NMAC’s 2015 Youth Initiative sponsored by ViiV Healthcare & Magic Johnson Foundation, . Since the 2015 USCA ,  Manny Venegas,  Seattle, Washington, Amanda Rodriguez and Jose Nazario  both of PuertoRico, have re-dedicated and declared themselves as emerging leaders in the struggle against HIV armed with information, knowledge and lessons learned at the conference. Read more about their planned 2015 National Latino AIDS Awareness Day activities and events.

CDC Supports New WHO Early Release HIV Treatment and PrEP Guidelines



CDC welcomes today’s announcement by the World Health Organization (WHO) of new Early Release HIV Treatment and Pre-Exposure Prophylaxis (PrEP) guidelines that will significantly increase the number of people eligible for life-saving anti-retroviral treatment (ART) and expand access to a powerful tool for preventing HIV among those at greatest risk.

These recommendations are a major step forward in the global fight against HIV. They have the potential to dramatically reduce transmission of HIV worldwide, increase the widespread use of PrEP among those who need it most, and help those living with HIV live longer, healthier lives.

The new WHO guidelines call for treatment for all individuals living with HIV – regardless of CD4 count. This is a dramatic shift from existing WHO guidelines that recommend ART for those with compromised immune systems (CD4 counts less than 500) and other vulnerable populations such as children, pregnant women, and people with TB. The new guidelines also recommend daily oral PrEP as an additional prevention choice for those at substantial risk for contracting HIV as part of a combination prevention approach.

Thanks to recent scientific breakthroughs, we now know unequivocally that early and effective treatment not only reduces HIV transmission but also significantly improves health outcomes for those living with HIV. The research on PrEP is also strong. PrEP has been shown in many studies and “real world” situations to reduce the risk of HIV infection by more than 90% among those who regularly take their medications.

While the science is clear, today’s guidelines are a call to policymakers and the public health community worldwide to translate that science into action. The WHO Early Release Guidelines support countries in expanding access to HIV treatment and affirm the promise of PrEP as an important part of a comprehensive response to HIV.

Today’s announcement aligns with two key U.S. recommendations. In 2012, the U.S. Department of Health and Human Services (HHS) issued treatment guidelines recommending ART for all patients diagnosed with HIV infection. In 2015, this was upgraded to an A1 recommendation, based on the highest quality evidence (a randomized controlled clinical trial) In 2014, CDC issued first-ever clinical guidance recommending physicians consider advising the use of PrEP for gay and bisexual men, heterosexuals, and injection drug users at substantial risk for HIV infection.

In collaboration with other United States agencies and global partners, CDC and the National Institutes of Health, both part of HHS, have been at the forefront of PrEP research efforts. CDC also is helping to increase access to ART for those who need it around the world.

With 15 million people now on ART and recent reductions in HIV across the globe, we know that together we can make continued progress in HIV prevention and treatment. But with more than 22 million people living with HIV who are not yet on treatment and more than 2 million new infections in 2014 alone, more needs to be done. We hope these recommendations will encourage the global HIV community to act.

Expanding Quality Care and Treatment

CDC is expanding global HIV/AIDS care and treatment services to save lives and prevent new infections

Care and treatment services help prevent new HIV infections, save lives, and provide hope to people and countries crippled with HIV/AIDS. As a key partner agency for the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), CDC helps countries plan, implement, and evaluate clinical services for HIV/AIDS care and treatment. These services include innovative approaches targeting hard-to-reach and most-at-risk populations.

CDC also works to leverage PEPFAR resources by linking them to other mainstream healthcare services. This integrated health care approach strengthens a country’s entire health care system as well as HIV service delivery effectiveness, efficiency, and sustainability.

Scientific and technical expertise to strengthen and expand HIV care and treatment services

CDC works with Ministries of Health and other key partners to ensure that HIV/AIDS care and treatment services are high quality, cost effective, and reach HIV positive populations by:

  • Providing ongoing technical expertise through CDC’s unique workforce of highly trained clinicians, epidemiologists, public health advisors, and health scientists. <!– Examples of activities include the following:
    • Translating World Health Organization guidance into effective program implementation and strategies tailored to each country’s unique context and epidemic.
    • Developing and disseminating protocols, tool kits, and training curricula to improve program implementation and to accelerate antiretroviral treatment service delivery, prevention of mother-to-child HIV transmission, and pediatric HIV care and treatment.
    • Working with regulatory councils and professional bodies to ensure defined scopes of practice, legal authority, and credentialing practices are updated and consistent with PEPFAR’s HIV care and treatment guidelines.


  • Identifying, evaluating, and replicating innovative interventions that are low-cost, high impact approaches to service delivery. CDC also links HIV services to other healthcare services to strengthen a country’s entire health care system. <!– Examples of activities include the following:
    • Developing a Basic Care Package that bundles high impact, inexpensive, easily implemented interventions to minimize the susceptibility of HIV-infected persons to common infections such as malaria, sexually transmitted diseases, and those caused by unsafe water.
    • Working to accelerate the integration of HIV and tuberculosis (TB) services through a TB/HIV Care and Treatment Program with services including HIV testing and counseling in TB clinics and referral to HIV care and treatment and screening HIV patients for TB in antiretroviral drug treatment clinics. The program helps countries develop guidelines for HIV-related TB diagnosis, treatment, and prevention. CDC also developed TB infection control resources to assist countries with translating guidelines into simple actionable steps at the facility level.


Critical leadership for transitioning sustainable laboratory systems and services to local country ownership

CDC collaborates with Ministries of Health and other key partners to increase country ownership and sustainability of care and treatment programs by:

  • Transitioning care and treatment programs to local organizations while strengthening capacity and ensuring quality service delivery by leveraging CDC’s in-country presence and highly skilled staff. <!– An example of this activity includes the following:
    • Transitioning HIV/AIDS care and treatment service delivery of the Track 1.0 Antiretroviral Treatment program from U.S.-based partners to in-country governments and indigenous organizations while maintaining uninterrupted quality services to patients.


  • Strengthening the health workforce in countries to provide HIV care and treatment, including improving and expanding education to produce more physicians, nurses, laboratorians, counselors, and pharmacitsts, and helping develop national standardized training programs to improve the quality of health workers already in the workforce (e.g., pediatrics, new treatment protocols, and TB).

Notable Accomplishments

Transitioning of the Track 1.0 Antiretroviral Treatment Program

  • CDC and the Health Resources and Services Administration (HRSA) initiated the Track 1.0 program in 2004 to rapidly scale-up antiretroviral treatment (ART) delivery initially through U.S.-based partners. Since that time, CDC has been working with Ministries of Health to transition HIV/AIDS care and treatment service delivery to local country ownership in 13 countries.

Integration of HIV/Tuberculosis Care and Treatment Programs

  • Tuberculosis (TB) is the most common opportunistic infection for people living with HIV and one of the leading causes of death. CDC works with Ministries of Health to expand testing and counseling of TB patients, and collaborates with the World Health Organization to develop and disseminate protocols, training, and policies to improve the integration of HIV and TB services.

The Basic Care Package

  • CDC-led research led to the development of a novel approach to integrate evidence-based interventions that can help reduce deaths, hospital visits, and illnesses among HIV-positive people and their families. The Basic Care Package bundles high impact, low cost interventions that are easy to implement to minimize the susceptibility of HIV-infected persons to common opportunistic infections.